Narrative/Learning Objectives:

•Explain the proposed mechanisms by which High-Flow Nasal Cannula (HFNC) therapy may alleviate respiratory distress.
•Identify patients who are appropriate candidates for HFNC on the Pediatric Hospital Medicine (PHM) service.
•Describe when to initiate, escalate, and wean HFNC therapy, and outline strategies for managing decompensation in patients receiving HFNC.
Session date: 
11/20/2025 - 2:00pm to 3:00pm EST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Children’s National Hospital designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Participation
    Successful completion of this continuing education activity.
Please login or register to take this course.
Faculty List: 

Kitman Wai, MD

has no relevant financial relationships to disclose at this time.